Bumper Offer - Urjas oil Just @ Rs. 1
Brilinta 60 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Heart Attack. Secondary and off-label uses of Brilinta 60 Tablet have also been mentioned below.
The optimal dosage of Brilinta 60 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Brilinta 60 Tablet can also lead to other problems, which have been listed below. These side effects of Brilinta 60 Tablet are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Brilinta 60 Tablet's effect during pregnancy is Moderate and Unknown while nursing. Further, the section on Brilinta 60 Tablet related warnings talks about Brilinta 60 Tablet's effects on the liver, heart and kidney.
Brilinta 60 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease, Bradycardia (Slow Heart Rate), Peptic Ulcer are examples of such conditions. The section on Brilinta 60 Tablet contraindications lists all such conditions.
Drug reaction of Brilinta 60 Tablet with other medicines has been reported. See below for a complete list.
You should also be aware that Brilinta 60 Tablet is safe while driving, and is addiction.
Brilinta 60 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Brilinta 60 Tablet is used -
Severe
Moderate
Mild
Is the use of Brilinta 60 Tablet safe for pregnant women?
Brilinta can have harmful effects in pregnant women. If you experience any discomfort after using Brilinta, then discontinue the use and take your doctor's advice.
Is the use of Brilinta 60 Tablet safe during breastfeeding?
No research work has been carried out till date on effect of Brilinta on breastfeeding women. So it is not known whether taking Brilinta will cause side effects or not.
What is the effect of Brilinta 60 Tablet on the Kidneys?
Brilinta is not harmful for kidneys.
What is the effect of Brilinta 60 Tablet on the Liver?
Brilinta may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Brilinta 60 Tablet on the Heart?
Side effects of Brilinta rarely affect the heart.
Brilinta 60 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Brilinta 60 Tablet unless your doctor advises you to do so -
Is this Brilinta 60 Tablet habit forming or addictive?
No, there is no any evidence that Brilinta 60 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Brilinta 60 Tablet as it does not make you drowsy.
Is it safe?
Yes, but take Brilinta 60 Tablet only as per medical advice.
Is it able to treat mental disorders?
Brilinta 60 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Brilinta 60 Tablet
Due to a lack of research, nothing can be said about the consequences of taking Brilinta 60 Tablet together with food.
Interaction between Alcohol and Brilinta 60 Tablet
Information about the interaction of Brilinta 60 Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Brilinta® (ticagrelor)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1204-1205
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Brilinta® (ticagrelor)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1204-1205
